Re: Stop the Drug Industry Swag


TC wrote:
http://www.latimes.com/news/printedition/california/la-ed-stanford16sep16,1,4643088.story?coll=la-headlines-pe-california

Stop the Drug Industry Swag
Stanford sets the pace for curbing pharmaceutical companies' influence
on doctors.
September 16, 2006


WHEN A PATIENT GETS a prescription from her doctor, she shouldn't have
to worry that the drug was selected because of a pharmaceutical
company's marketing skills. That's why Stanford University Medical
Center's announcement this week that it's no longer allowing physicians
to accept gifts from pharmaceutical sales representatives is so
refreshing. No more free lunches. No drug samples. Not even those cute
mugs. It's an austere measure that other medical centers should follow.

The relationship between pharmaceutical companies and physicians -
their protestations to the contrary - is uncomfortably close. The
drug industry doles out $21 billion a year in marketing (90% directed
at physicians), far more than it spends on consumer advertising. And
it's often money well spent; studies have shown that even small gifts
increase doctors' sense of obligation to pharmaceutical makers,
especially free drug samples that clearly sway decisions to stick with
expensive medications that often aren't any more effective than cheaper
competitors.

ADVERTISEMENT
The drug industry says such bans, which also have been enacted in the
last two years by Yale University and the University of Pennsylvania,
will make it more difficult for doctors to interact with and learn from
sales representatives. This is true. But so what? Drug reps typically
keep physicians up to speed on pharmaceutical pipelines and medical
research, something research shows doctors don't do enough on their
own. But physicians, who control patients' lives with their decisions,
must be held to the highest ethical standards possible to ensure that
those decisions are based on the best empirical knowledge, not personal
gain or social proximity.

Stanford's decision also is further proof that voluntary drug industry
guidelines aren't working, as if that is a surprise. After threats from
Congress to crack down on industry swag, manufacturers agreed in 2002
to limit gifts to those of "modest value." Still, companies continue to
spend millions flying physicians to winter conferences in Hawaii and
throwing lavish parties. Meanwhile, sanctions against doctors who
accept forbidden costly gifts are rare. Considering the supply isn't
likely to stop anytime soon, hospitals should follow Stanford's lead
and cut the demand with similar bans.

This won't be cheap. Stanford estimates that making up for all those
"free" lunches and drug samples could cost the medical center millions.
But when it comes to patient safety, and the fundamental importance of
trusting your doctor for impartial information, it's money well spent.

****************

Way to go Stanforf!!!!! Finally, someone who understands what
professional credibility means.

TC

http://www.mercurynews.com/mld/mercurynews/news/opinion/15547088.htm

Banishing doctors' conflict of interest
STANFORD WALLS OFF ITS HOSPITAL FROM DRUG INDUSTRY LURES
Mercury News Editorial
It's well documented that no one better understands the concept of
buying in bulk than the pharmaceutical industry. Last year it spent a
whopping $20 billion in marketing its products to doctors across the
country.

Finally, a major medical institution in California has demonstrated the
ethical fortitude to say enough is enough. Stanford University's
Medical Center, which includes its medical school, Stanford Hospital
and Lucile Packard Children's Hospital, has announced that it will no
longer allow staff and students to receive gifts from drug suppliers.

Lavish spending on doctors and medical students is done in part to
influence physicians' thoughts on the use of certain drugs. It's
essential that patients know that their doctors are basing their
decisions on treatment free of conflicts of interest.

Pharmaceutical companies should still be allowed to maintain their
connections to medical schools, researchers and physicians through
research and development. But imposing potential conflicts of interests
on patient care is another matter.

Stanford follows in the footsteps of Yale University and the University
of Pennsylvania in implementing such a policy. Other hospitals, clinics
and physicians in California should follow Stanford's lead.

The pharmaceutical industry argues that its marketing efforts --
including free trips and a variety of gifts for doctors -- are the best
means to keep physicians informed on the latest products. But it
doesn't take eight years of medical school to determine that
pharmaceutical companies have ulterior motives. Drug companies don't
spend billions of dollars without receiving a return on investment.

Stanford, under the leadership of Medical School Dean Philip Pizzo,
should be applauded for its decision to reinforce the public's trust in
health care. The pharmaceutical industry should take note and limit its
efforts to more ethical means of communication about products.

****************

TC

.

Relevant Pages

  • Re: Stop the Drug Industry Swag
    ... Stop the Drug Industry Swag ... That's why Stanford University Medical ... increase doctors' sense of obligation to pharmaceutical makers, ... expensive medications that often aren't any more effective than cheaper ...
    (sci.med.nutrition)
  • Stop the Drug Industry Swag
    ... Stop the Drug Industry Swag ... Center's announcement this week that it's no longer allowing physicians ... increase doctors' sense of obligation to pharmaceutical makers, ...
    (sci.med.nutrition)
  • The Pill Pushers
    ... When Shahram Ahari went to work at pharmaceutical giant Eli Lilly ... His job was to schmooze with doctors in order to get them to prescribe ... drug has not been approved by health regulators. ... The number of detailers here jumped from 3,990 to 5,190 ...
    (misc.health.alternative)
  • The Pill Pushers
    ... When Shahram Ahari went to work at pharmaceutical giant Eli Lilly ... His job was to schmooze with doctors in order to get them to prescribe ... drug has not been approved by health regulators. ... The number of detailers here jumped from 3,990 to 5,190 ...
    (sci.med.psychobiology)
  • Trial: Popular cholesterol drug fails to improve heart disease
    ... CHICAGO, Illinois -- Leading doctors urged a return to older, tried-and-true treatments for high cholesterol after hearing full results Sunday of a failed trial of Vytorin. ... Millions of Americans already take the drug or one of its components, ... But doctors were stunned to learn that Vytorin failed to improve heart disease even though it worked as intended to reduce three key risk factors. ...
    (soc.senior.issues)